You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cannabinoids for Cancer Treatment: Progress and Promise
|
|---|---|
| Published in |
Cancer Research, January 2008
|
| DOI | 10.1158/0008-5472.can-07-2785 |
| Pubmed ID | |
| Authors |
Sami Sarfaraz, Vaqar M. Adhami, Deeba N. Syed, Farrukh Afaq, Hasan Mukhtar |
| Abstract |
Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy. |
X Demographics
The data shown below were collected from the profiles of 112 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 46 | 41% |
| United Kingdom | 7 | 6% |
| Canada | 3 | 3% |
| Bosnia and Herzegovina | 2 | 2% |
| Indonesia | 2 | 2% |
| Malaysia | 1 | <1% |
| Italy | 1 | <1% |
| Portugal | 1 | <1% |
| Uruguay | 1 | <1% |
| Other | 6 | 5% |
| Unknown | 42 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 101 | 90% |
| Practitioners (doctors, other healthcare professionals) | 8 | 7% |
| Scientists | 2 | 2% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 318 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 2% |
| United Kingdom | 2 | <1% |
| Uruguay | 1 | <1% |
| Unknown | 308 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 49 | 15% |
| Researcher | 48 | 15% |
| Student > Ph. D. Student | 44 | 14% |
| Student > Master | 44 | 14% |
| Student > Postgraduate | 19 | 6% |
| Other | 54 | 17% |
| Unknown | 60 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 57 | 18% |
| Agricultural and Biological Sciences | 55 | 17% |
| Medicine and Dentistry | 50 | 16% |
| Chemistry | 18 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 5% |
| Other | 52 | 16% |
| Unknown | 70 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 354. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2023.
All research outputs
#91,177
of 25,401,381 outputs
Outputs from Cancer Research
#54
of 18,623 outputs
Outputs of similar age
#155
of 169,458 outputs
Outputs of similar age from Cancer Research
#1
of 162 outputs
Altmetric has tracked 25,401,381 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,623 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.